RxDoctor Payments Data

Albert Leis, MD

Family Medicine · Louisville, KYNPI 1831191592

Payments from drug & device makers

$1,092in general payments, 2019–2025

Across 80 payments — averaging $13.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$442
  • Novo Nordisk$324
  • Pfizer$91
  • GSK$65
  • Exact Sciences$46
  • Amgen$41
  • plus $84 from 4 others

What the payments were for

  • Food & beverage$1,092100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie37$442
Novo Nordisk21$324
Pfizer5$91
GSK5$65
Exact Sciences3$46
Amgen3$41
Smith+Nephew2$31
Lilly USA, LLC2$27
Novartis1$14
AstraZeneca1$12

How this compares

$1,092 in reported general payments places this provider in the 55th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$32,886
Medicare patients
164
Services billed
705

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol22$36,471
XareltoRivaroxaban22$33,679
JardianceEmpagliflozin19$32,121
EliquisApixaban11$13,715
RybelsusSemaglutide12$11,433
Atorvastatin Calcium655$4,407
Metoprolol Succinate181$2,310
Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril132$1,924
Amlodipine Besylate358$1,729
Pantoprazole Sodium120$1,270
Omeprazole130$1,175
Levothyroxine Sodium136$1,156
Potassium Chloride44$990
Lisinopril176$961
SynthroidLevothyroxine Sodium32$865

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$12$36,47122 claims
PfizerEliquis$91$13,71511 claims
Novo NordiskRybelsus$324$11,43312 claims
AbbVieSynthroid$442$86532 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →